Feasibility of a Multi-Channel Intervention to Promote Colorectal Cancer Screening Among American Indians in Oklahoma
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
The Accelerating Colorectal Cancer Screening and follow-up through Implementation Science (ACCSIS) Program addresses major regional CRC screening disparities among AI in Oklahoma. The investigators are engaged in a participatory and collaborative effort with Tribal Nations, Area Indian Health Boards, and Indian Health Service (IHS) healthcare facilities. The overall objective of this proposal is to leverage these relationships and examine the feasibility of co-developing and disseminating a v-TCHE as part of a multi-channel communication intervention. To achieve this objective, the investigators have partnered with IHS Clinton Service Unit, which serves members of the Cheyenne and Arapaho Tribes. The intervention will be disseminated across two channels: (1) Social Media (i.e., accessed via online study adverts) and (2) Clinic (i.e., direct messaging to patients via a study link in a SMS text). Across both channels, the investigators will examine reach of the intervention and its potential efficacy via a randomized controlled trial. Once participants click on the study link they will be randomized 1:1 to one of two intervention conditions: (1) watch a Narrative Testimonial Video of a real-life Tribal community health educator (control) or (2) an interaction with a v-TCHE. Participants will then complete a post-intervention survey, in which they can click to order a FIT kit afterwards.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Wiek od 45 do 75 lat
- •Mieszkanie na terenie objętym opieką IHS Clinton Service Unit
- •Płynna znajomość języka angielskiego i umiejętność czytania na poziomie co najmniej szóstej klasy
- •Deklaracja pochodzenia rdzennego amerykańskiego lub posiadanie dokumentu CDIB
✗ Disqualifies
- •Osoby, które są aktualnie objęte badaniami przesiewowymi raka jelita grubego
- •Osoby, które wykonały badanie FIT w ciągu ostatniego roku
Simplified criteria — AI translation
Trial details
- Minimum age
- 45 Years
- Maximum age
- 75 Years
- Last updated (source)
- July 30, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (1)
TSET Health Promotion Research Center
Oklahoma City, United States
Trial contact
Jordan Neil, PhD
Adam Alexander, PhD
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/31/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.